Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Predicting cardiovascular problems in liver transplant patients

02.03.2006


New study finds PROCAM and SCORE most accurate



Two methods of assessing a patient’s risk of cardiovascular events--SCORE and PROCAM--proved more valuable for liver transplant recipients than an alternative method, according to a new study. These findings are published in the March 2006 issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS). Published on behalf of the societies by John Wiley & Sons, Inc., the journal is available online via Wiley InterScience (www.interscience.wiley.com/journal/livertransplantation).

Patients who receive liver transplants often have an increased prevalence of cardiovascular risk factors, and cardiovascular events are a major source of their morbidity and mortality. Due to excellent long-term survival, there is an increasing emphasis on identifying transplant recipients at risk for immunosuppression-related late complications. Understanding each transplant recipient’s risk for cardiovascular events is one important consideration.


In search of the best method of estimating a patient’s risk of a cardiovascular event, researchers led by Dr. Olaf Guckelberger of the Department of General, Visceral and Transplantation Surgery at Charité – Campus Vichow-Klinikum in Berlin, Germany, sought to identify relevant independent variables, as well as the algorithm that would most accurately quantify a transplant candidate’s risk of future cardiovascular disease.

The researchers retrospectively studied 303 patients who had received a liver transplant between 1988 and 1994. They gathered clinical and demographic data at six months post-transplant, including age, gender, smoking-status, family history of cardiovascular disease, arterial blood pressure, height, weight, medication and serum levels of creatinine, total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, and glucose after fasting. They then used this data to calculate three established cardiovascular risk scores: the Framingham risk score (FRS), the German Prospective Cardiovascular Münster Study (PROCAM), and the European Systematic Coronary Risk Evaluation Project (SCORE), all of which predict the 10-year-risk of coronary or cardiovascular events or fatalities. They compared the actual incidence of cardiovascular events, such as myocardial infarction and coronary heart disease, over 10 years post-transplant to better understand the predictive power of each score.

"In our liver transplant population at six months post-transplantation, PROCAM and SCORE provided an excellent measure to discriminate between patients at high or low risk for coronary events," the authors report. The Framingham risk score, however, did not identify high-risk liver transplant recipients as accurately.

In an editorial published in the same issue, Christopher P. Appleton, M.D. and colleagues of the Mayo Clinic confirm that assessing short and long term cardiovascular risk is an important aspect of pre-liver transplant evaluation, however, they suggest that the Framingham risk score does have some predictive power.

While they agree with Guckelberger’s assertions that it is important to determine cardiovascular risk in patients in need of a liver transplant, the authors add, "The assertion that there are significant differences in the three global CV disease risk stratification algorithms studies is less certain." They suggest that aspects of the study--such as information about transplant patients who were not included--require further investigation.

Both groups of authors propose additional studies to validate the current findings before applying them to liver transplant populations. Appleton, et al., suggest future prospective studies that add newer reported risk factors to those previously established, including serum high sensitivity C-reactive protein, fibrinogen, homocysteine, lipoprotein and apolipoproteins A1 and B.

David Greenberg | EurekAlert!
Further information:
http://www.interscience.wiley.com/journal/livertransplantation

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>